YONGKANG SAIEN TECHNOLOGY CO., LTD – Trademark Portfolio

Entity Type: 99

YONGKANG SAIEN TECHNOLOGY CO., LTD holds 1 U.S. trademark filed with the United States Patent and Trademark Office (USPTO), with a strong focus on Class 28 (Toys & Sporting Goods) — 1 filings in this category. Currently, 1 trademark is registered. Notable registered marks include VANMED. The owner is based in JINHUA CITY, ZHEJIANG PROVINCE.

ROOM 2911, 29TH FLOOR, JINSHAN BUILDING

ZONGBUZHONGXIN, DONGCHENG STREET, YONGKANG, CITY

JINHUA CITY, ZHEJIANG PROVINCE 321300 , CN

1 Total Trademarks

Add to watchlist:

No watchlists yet
Loading...
By Date
By Name
Filter by Class:

VANMED
VANMED
Registered 2020

Trademark Classifications

YONGKANG SAIEN TECHNOLOGY CO., LTD's trademark portfolio spans 1 Nice Classification class, reflecting the scope of goods and services protected under their brand portfolio.

28
Toys & Sporting Goods (1 filing)

Games and playthings; gymnastic and sporting articles; decorations for Christmas trees

Frequently Asked Questions

How many trademarks does YONGKANG SAIEN TECHNOLOGY CO., LTD have?

YONGKANG SAIEN TECHNOLOGY CO., LTD has 1 U.S. trademark filed with the USPTO. Of these, 1 registered.

What trademark classes does YONGKANG SAIEN TECHNOLOGY CO., LTD file in?

YONGKANG SAIEN TECHNOLOGY CO., LTD files trademarks across 1 Nice Classification class. The most active classes are Class 28 (Toys & Sporting Goods). Class 28 covers games and playthings; gymnastic and sporting articles; decorations for christmas trees.

What are YONGKANG SAIEN TECHNOLOGY CO., LTD's most well-known trademarks?

YONGKANG SAIEN TECHNOLOGY CO., LTD's registered trademark portfolio includes well-known marks such as VANMED. These are among 1 currently registered trademark in the portfolio.

What is YONGKANG SAIEN TECHNOLOGY CO., LTD's trademark registration success rate?

YONGKANG SAIEN TECHNOLOGY CO., LTD has a 100% trademark registration rate, with 1 out of 1 resolved applications resulting in successful registration. Currently, 0 applications are pending review.